Bernard-Soulier syndrome (BSS) giant platelets have defective and/or deficient glycoprotein (GP) Ib/lX complexes, causing absent ristocetin-induced aggregation, defective interaction with von Willebrand factor, morphologic abnormality, and a clinical bleeding tendency. Recently several mutations have been described in the platelet GPlba gene in individuals exhibiting the BSS phenotype. We have studied a family with classical BSS, and have excluded lesions at the GPlba locus by restriction fragment length polymorphism linkage analysis. Analysis of the genes for two other components of the platelet GP1b:IX complex, namely GPlbfi and GPIX, showed two different missense mutations in the coding region of the GPlX gene: an A-G transition in codon 21 results in conversion of an aspartic acid to glycine and an A -G change in codon 45 converts an asparagine res-ERNARD-SOULIER syndrome (BSS) is a rare congen-B ital bleeding disorder that is usually inherited in an autosomal recessive manner.' It is characterized by morphologically abnormal giant platelets and reduced or absent ristocetin-induced platelet aggregation (RIPA), not reversed by the addition of normal plasma. The platelet membrane glycoprotein (GP) IbIX complex has consistently been shown to be deficient or defective in platelets from patients with BSS. This is thought to account for the defective, von Willebrand factor (vWF)-mediated platelet adhesion to exposed subendothelium manifested by BSS platelets. At least four separate gene products may fail to be expressed normally in the BSS platelet membrane, ie, GPIba chain, GPIbP chain, GPIX, and GPV.2- 6 The a chain of GPIb has a molecular weight of approximately 140 Kd. Its extracellular domain has been described as a flexible rod that projects from the platelet membrane and also contains binding sites for both thrombin and v W F .~,~ The GPIbP chain is smaller (24 Kd) and disulphide-linked to GPIba.' GPIX (22 Kd) is noncovalently bound to GPIb and recent evidence suggests that GPV (82 Kd) is also associated with the complex in a noncovalent manner.'O All four glycoproteins are members of the leucine-rich glycoprotein (LRG) family characterized by the leucine-rich repeat motifs of which they contain various numbers (LRG repeats). Consensus sequences have also been identified in the regions flanking the LRG repeats."
The primary structure of the gene for GPIba has been determined12. 13 and cDNAs for GPIbP and GPIX have been cloned and seq~enced?,~~~" The striking feature of the GPIba gene is its intron-depleted structure, with one small intron immediately upstream of the initiation codon and the coding sequence contained in its entirety within exon 2. Although partial amino-acid sequence has been determined for GPV,'6317 the gene has yet to be cloned. However, there is evidence suggesting that GPV, unlike GPIba, GPIbP, and GPIX, may not be essential for membrane expression of the GP1b:IX complex." In BSS, there are often demonstrable levels of residual subunit proteins, but the relative quantities of each can vary from pedigree to ~edigree.~-~-" Although generally each protein is significantly reduced in quantity or idue to serine. Three affected individuals are doubly heterozygous for these mutations, which alter conserved residues in or flanking the GPlX leucine-rich glycoprotein motif. Both mutations create new recognition sites for the enzyme Fnu 4H1; therefore, this enzyme was used to screen 60 normal subjects (1 20 alleles). Neither mutation was detected in any subject other than direct relatives of the affected individuals. Although low levels of GPlb were demonstrable by both flow cytometry and immunoblot analysis in an affected individual's platelets, there was no evidence of GPlX immunoreactivity. We propose that expression of abnormal GPlX prevents stable assembly of the GPlb/lX complex, causing BSS in the doubly heterozygous individuals in this family. There have been no reports to date of mutations affecting the other components of the GPIbIX complex, although current evidence implicates at least one other ~o c u s .~,~~ In this study, we report two missense mutations in the GPIX gene and present evidence supporting the premise that these mutations impede the expression of GP1b:IX complexes in the platelet membrane and are, therefore, responsible for the clinical bleeding tendency in a BSS kindred.
MATERIALS AND METHODS
The propositus (11-5) is a 59-year-old female with a lifelong bleeding disorder who presents frequently with episodes of mucosal bleeding, particularly melena. Two of her siblings are similarly affected (11-3 and 11-6, Fig 1) . RIPA was consistently absent in all three affected individuals and thrombocytopenia with morphologically abnormal giant platelets was also noted. Immunochemical staining of platelet membrane antigens demonstrated a near absence of GPIb, A diagonal stroke on male (square) or female (round) symbols indicates that the subject is deceased.
consistent with a diagnosis of BSS. Blood samples were taken from the affected patients, one unaffected sister (11-I), and the youngest daughter of the propositus (111-6). Informed consent was obtained from each participant.
Genomic DNA was extracted from whole blood collected into EDTA as described elsewhere.23 Oligonucleotides for polymerase chain reaction (PCR) and for sequencing were designed according to the published sequences of GPlbu, GPlbB, and GPIX,9.'2,'5 and synthesised on an ABI-PCR mate instrument (Applied Biosystems Inc, Warrington, UK). Primer pairs and their coordinates as entered on the European Molecular Biology Laboratory (EMBL) (Heidelberg, Germany) database are shown in Table 1 . GP9b and GPB2 were also synthesized with a biotinylated 5' end to yield GP9bbio and GPB2bio, respectively.
PCR reactions were performed on a DNA thermal cycler (Perkin Elmer Cetus, Norwalk, CT). For each complementary pair of oligonucleotides the conditions were optimized to ensure maximum yield and specificity. One hundred-microliter volumes were used, containing 200 to 600 ng of DNA, 2 U of Taq polymerase (Promega, Madison, WI), and 300 ng of each primer. When a biotinylated primer was used, only 100 ng of each primer was added. Control tubes to which no DNA was added were included with each batch of reactions. PCR buffer was supplied by Promega and was made up with each dNTP to a concentration of 200 pmol/L. Cycling conditions for the primer pairs were 5 minutes at 94°C. then 32 cycles with 35 seconds at 94"C, 1 minute at the annealing temperature (see below), and I minute at 72°C (plus 3 additional seconds per cycle). All reactions were completed with IO minutes at 72°C. Annealing temperatures were asfollows: GPlbal/2 and GP9a/b, 53°C; GPIba3/4,56"C; and GPBI/2, 48°C. Consistent amplification with GPBlj2 required dimethyl sulfoxide (DMSO) in the reaction mix at a concentration of 10%. Reaction products were checked by agarose gel electrophoresis and subsequent restriction digests were performed in 20 pL reactions for 1 hour in the appropriate buffers and at the appropriate temperatures.
Singlestranded conjbrmation polymorphism (SSCP) analysis. We have developed a modification of previously described metho d~~~,~~ that we have termed consecutive SSCP. The principle is illustrated in Fig 2. PCR reactions were performed as above, except that '*P-labeled dATP or dCTP was added to the reaction mixes (approximately 2 pCi in each reaction tube). For consecutive SSCP, a biotinylated antisense primer was used and the product was concentrated by binding to streptavidin-coated magnetic beads (see below; Dynabeads; Dynal AS, Oslo, Norway). This allowed the residual reaction products including unincorporated radiolabeled nucleotides to be removed using a magnetic separator. The beads were then DNA anal.vsis. washed once with sterile distilled water and resuspended in 17 pL of the same. To this was added 1 p L of restriction enzyme and 2 pL of the appropriate IOX buffer. After 1 hour of incubation, the cleaved fragments were separated (again using the magnetic separator) from the remaining fragments that were still attached to the beads by their biotinylated end (the antisense primer). The beads were again washed and resuspended in sterile distilled water in preparation for the next restriction digest. In this way it was possible to run fragments of optimal length for SSCP analysis in separate lanes of a polyacrylamide gel, simplifying interpretation and allowing identifiable bandshifts to be directly ascribed to the correct fragment. The final fragment can be analyzed either by cleaving the PCR product close to the biotinylated end or alternatively by disrupting the biotin-streptavidin bond directly, which requires heating to 95°C or more for IO minutes. Each cleavage product was analyzed separately as follows.
One to three microliters ofthe product was made up to 10 pL with SSCP buffer (80% formamide, 0.1 % Bromphenol Blue, 0.1 % XyleneCyanol, I mmol/L EDTA, 10 mmol/L NaOH); samples were denatured at 90°C for 3 minutes, transferred to ice, and then 4 pL was loaded onto a 4.5% polyacrylamide gel (39: 1 acrylamide to bisacrylamide) that was run at 4°C and at 40 W constant power; gels were then dried under vacuum at 80°C and exposed to X-ray film at room temperature ( I to 3 days).
Amplified DNA was sequenced as described.26 Briefly, the PCR product was bound to magnetic beads according to the manufacturer's instructions (Dynabeads). The strands were separated by adding 0. I mol/L NaOH and removing the supernatant while using the magnetic separator. The beads. to which were attached the biotinylated strands. were then washed and resuspended in IO pL sterile distilled water. Sequencing reactions were performed using T7 DNA polymerase according to the protocol sup plied by the manufacturers (Pharmacia. Milton Keynes. UK). Either the original primers used for amplification or specific internal sequencing oligonucleotides were annealed to the template DNA (Table   I ) and the reactions were mixed by gentle pipette action only. The reaction products were heated to 72°C for 3 minutes before loading on a denaturing polyacrylamide gel. The supernatant was separated from the beads by using the magnetic separator once more immediately before loading the samples.
Venous blood was taken into heparin and left mixing gently at room temperature. Aliquots of whole blood were diluted with phosphate-buffered saline (PRS). pH 7.2, according to the platelet count such that each aliquot of 100 pL contained IO6
platelets.
The following antibodies were used to demonstrate platelet membrane GP expression: anti-GPllb/llla fluorescein isothiocyanate to block any excess antibody. Control samples that were incubated with secondary antibody only were included along with normal control samples. Cell suspensions in a final volume of 250 pL were analyzed in a FACStar flow cytometer ( W o n Dickinson, Mountain View, CA). Levels ofexpression of the target proteins were determined by measuring red (GPlb) and green (GPIX and GPllb/llla) emission.
Platelet-rich plasma was prepared by allowing blood taken into anticoagulant to settle at room temperature and pipetting off the plasma fraction. After two washes with PBS, the platelets were pelleted and resuspended in 50 mmol/L Tris buffer containing 2% sodium dodecyl sulfate (SDS). Ten micrograms of protein from each platelet extract was run in nonreduced form on a polyacrylamide gel. Gels were electrophoretically transferred to nitrocellulose and left to soak for 30 minutes in buffer containing 50 mmol/L Tris, I50 mmol/L NaCI, 5 mmol/L EDTA, 0.05% Triton X-100, and 0.25% gelatin. The nitrocellulose membranes were incubated with anti-GPlb or anti-GPIX antibodies for I to 2 hours
Immitnoblotring.
and then washed three times (IO minutes each) in fresh buffer. A goat antirabbit IgG antibody. conjugated with horseradish peroxidase (BioRad, Hemel Hempstead. UK) was added as the secondary antibody. After incubating for I further hour. the three washes were repeated. The nitrocellulose membranes were coated with Amenham ECL detection reagents (Amenham. Amenham. UK) and exposed to x-ray film for I to 30 minutes.
RESULTS
Two regions of the GPlba gene, both of which have been shown to be polymorphic, were selected for amplification: firstly, the 3' end of the gene spanning the Tuq I restriction site polymorphism reported by Finch et a1.22 ( I ) A 432-bp fragment was amplified using GPI ba3 and GPI ba4, incorporating the Tuq I polymorphism at nucleotide 5491 (EMBL database). The presence or absence of the Tuq I restriction site was determined by agarose gel electrophoresis ofthe PCR products after digestion with Tuq I, with cleavage at this site resulting in fragments of 252 bp and I80 bp. Within the family studied. this polymorphism was clearly not linked to the BSS phenotype because 11-3 and 11-5 were shown to be homozygous for different alleles (Fig 3) . Results obtained from these and other family members are summarized in Fig  4. Secondly. we looked at the region coding for the heavily glycosylated portion of the extracellular domain known as the macroglycopeptide domain. This region has been shown Gflba.
N1 N2 N3 11-3 II-5
II-6 II-5 N1 A B Fig 6. (A) SSCP analysis of DNA fragments containing the coding region for the GPlX gene amplified from genomic DNA as described. The resulting products (861 bp) were digested with Taq I to give fragments of 461 bp and 400 bp, a total of four single strands. A solitary bandshift was observed for t h e two BSS samples (11-3 and 11-5) when compared with three normals (N1 through 3). The experiment was repeated using t h e consecutive SSCP method outlined above (E) to identify with certainty the fragment responsible for the bandshift. (6) The 5 fragment was run separately, demonstrating that this fragment was responsible for the bandshift observed in (A). The two conformations seen, probably representing different strands of 461 bp (sense) and 463 bp (antisense). corresponded to the upper two (slower migrating) bands of (A). Two separate bandshifts were discernable here (see text).
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Homology between LRG sequences 45 a m + ser to contain a repeat motif corresponding to 13 amino-acid residues (codons 369-38 I of published sequence), present in variable number ( I to 3)." (2) A 752-bp fragment was amplified using GPlbal and GPIba2. It was possible to demonstrate fragment length polymorphism by agarose gel electrophoresis of the amplified products. Digestion of the PCR products with Avu 11 delineated the alleles more clearly, although the polymorphism was uninformative with respect to the family under investigation (Fig 5) . It was considered a likely possibility that the genes for GPIX and GPIbfi were structurally related to the GPIba gene. The GPIX gene is known to be small and located on chromosome 3.15 Primers were selected (GWa and GP9b) that spanned the coding region in its entirety. The region immediately upstream of the initiation codon was also included as this region is known to contain the sole intron in the GPlba gene. A fragment was amplified that was approximately 110 bp longer than the corresponding cDNA se-
GPIX.
quence (753 bp). To confirm the origin of the fragment, the 5' end was sequenced and a small intron of 108 bp was identified 12 bp upstream of the start codon. This sequence is presented in Table 2 . SSCP analysis (Fig 6) after a Tuq I digest of the GPIX gene identified a single bandshift, which appeared to be linked to the BSS phenotype. When the two fragments generated by Tuq I digestion were separated by consecutive SSCP analysis, an additional (apparently heterozygous) bandshift was observed that was also observed for the daughter of the propositus. The entire gene was subsequently sequenced for each family member who had provided a sample and for four normal subjects. Two separate single base-pair substitutions were identified in all three siblings with BSS such that they were heterozygous for both mutations (Fig 7A and B) . These substitutions predict the following alterations at the amino-acid level: codon 2 l Asp + Gly (GAC-GGC) and codon 45 Asn + Ser (AAC-AGC). The two unaffected family members who were tested (11-1 and 111-6) Sixty normal subjects were analyzed in this way, and neither substitution was detected outside the immediate family.
were found to be heterozygous only for the codon 21 substitution.
Despite full sequence analysis. it is not clear why the most slowly migrating band on SSCP analysis resolves in the patients as a single-shifted band as might be expected for a homozygous sequence irregularity.
Neither substitution was found in the normal subjects, but a heterozygous neutral substitution was identified in one subject at codon 28 (ACG-ACA. Thr). This latter substitution was presumed to have given rise to a shift observed on SSCP analysis of the same individual (not shown).
Both of the mutations found in the family with BSS were predicted to create restriction sites for the enzyme Fnu4H I. New bands could be identified on agarose gel electrophoresis of Fnu4H I-digested PCR product corresponding to each of the substitutions (Fig 8) . Therefore, it was possible to rapidly screen 60 subjects with normal platelet function for both the codon 21 and the codon 45 substitutions simultaneously. Neither substitution was identified in any individual unrelated to the family under investigation.
The GPlbB gene was also amenable to amplification from genomic DNA. suggesting that it had an introndepleted primary structure similar to that of the gene for GPlba. Using primers GPBl and GPBZ. it was possible to amplify a fragment that at 893 bp was the size predicted from the published cDNA sequence.' Because only limited sequence was available at the 5' end of the cDNA, the sense primer (GPB I ) corresponded to sequence coding for the signal peptide and thus it was not possible to establish the presence
GPlhS.
or absence of an intron upstream of the initiation codon. Consistent amplification required the presence of 10% DMSO in the reaction mix, possibly a consequence of the high G + C content of the gene (75% of the first 900 nucleotides). The DMSO was subsequently found to interfere with SSCP analysis and therefore consecutive SSCP analysis was performed on biotinylated product (see above). In this way it was possible to remove the DMSO and concentrate the radiolabeled product. Although polymorphisms were identified within the GPlbS coding region. none showed linkage to the BSS phenotype (Fig 9) .
Platelets from the propositus were analyzed for membrane expression ofGPlb, GPIX, and GPllb/ Fluorescence intensity + llla (Fig IO) . There was no significant difference in levels of expression ofGPllb/llla between the propositus and normal controls. GPlX expression was undetectable in the platelets of the propositus, with fluorescence intensity being the same as that for controls lacking the primary antibody (FMC-25).
However. there was evidence of residual GPlb expression on the patient's platelets. the results for which were clearly different from those for the control sample and also from the pattern obtained from another patient with BSS whose platelets were analyzed at the same time (data not shown). 
B
ftntniinoblo~titi~. In concurrence with the flow cytometric data. there was evidence of residual GPlb in the platelet extracts from the propositus (Fig I I) . A band was seen that corresponded to a molecular weight of 160 Kd. This band was observed for platelet extracts of both normal and BSS platelets. although the signal was clearly less intense for the BSS platelet extract.
When antibody directed against GPlX was used, a band was observed in the normal control sample corresponding to a molecular weight ofapproximately 32 Kd. This is somewhat 32kDa - For personal use only. on October 23, 2017. by guest www.bloodjournal.org From higher than previously reported and presumably indicates anomalous migration in the polyacrylamide gel system used. There was no evidence of any band when a BSS platelet extract was analyzed in identical conditions.
DISCUSSION
Recent studies have characterized mutations affecting GPIba in patients with BSS.'9-2' Mutations that modify vWF binding may result in an alternative phenotype, ie, pseudoor platelet-type von Willebrand's d i~e a s e .~~'~' In the latter cases, the mutations are dominant acting and situated within the vWF binding region of the molecule. In BSS, however, the mutations described are more heterogenous. The missense mutations that were identified in the current investigation indicate that lesions within the GPIX gene can also give rise to the BSS phenotype. Furthermore, in a Chinese hamster ovary (CHO) cell expression system, it has been shown that GPIX is a necessary requirement for membrane expression of the GP1b:IX complex, and the same seems to be true for both GPIba and GPIbP, but not apparently for GPV. 18 In the family reported here, involvement of the GPIba gene was excluded by the (fortunate) distribution of alleles at this locus. The intron-depleted structure of the GPIbP gene enabled us to screen for mutations using SSCP. Only polymorphic band shifts were found that helped to exclude this locus. Analysis of the GPIX gene, similar to that of the GPIbP gene, was facilitated by its intron-depleted structure and we were able to identify a single small intron of 108 bp. This intron was situated in a region showing close homology to the corresponding region in the GPIba gene, immediately upstream of the initiation codon.I5
The two single base-pair substitutions identified within the GPIX coding region both predict amino-acid substitutions affecting conserved residues within or flanking the single LRG repeat. The codon 45 asparagine to serine mutation changes a conserved residue within the core LRG motif, whereas the codon 21 aspartic acid to glycine mutation changes a conserved aspartic acid residue within the amino-terminal flanking sequence. Screening for these changes at DNA level failed to identify either mutation in 60 normals (120 alleles). It is likely that these missense mutations cause severe disruption of GPIX structure and it supports evidence that the GPIX molecule, although small, is of critical importance in the formation ofthe intact, functional complex. Mutant GPIX may be either rapidly degraded or else be present in a nonfunctional form, not recognized by the monoclonal antibody FMC-25. The bulk of the GPIX molecule lies outside the platelet membrane. There is a very small intracellular domain (6 residues) and a transmembrane domain that can be acylated with palmitic acid through a thioester linkage.3' The extracellular domain is largely composed of the single LRG motif and its flanking sequences. The current work serves to highlight the potential importance of this region, although it is not yet clear whether the LRG domain contributes directly to the structural integrity of the complex, perhaps by interacting with the single LRG domain ofGPIbP. The only other mutation affecting a residue from an LRG domain (to date) was identified in GPIbcu." This mutation was predicted to alter a conserved leucine residue and, interestingly, appears to cause a significant bleeding tendency and morphologically abnormal platelets in a dominant manner.
The GP1b:IX complex seems also to have an important role in the structural development of the platelet, possibly through its provision of an effective attachment between the membrane and, through actin-binding protein, the membrane skeleton. The platelets from the patients presented here have the characteristic morphologic abnormalities associated with BSS. The results of the flow cytometry suggest that the residual GPIb detected was present in the membrane of a distinct subpopulation of cells, (approximately 25% of cells counted) which can be observed as a secondary peak in the merged graph in Fig 10. This subpopulation may represent the younger platelets that then lose remaining GPIb during their circulatory life span, which is generally reduced in BSS. Further studies are required to test this hypothesis.
It is probable that the BSS phenotype represents the end result of diverse mutations affecting at least two loci involved in the assembly of the GPIb/IX complex on the platelet surface. Further studies on BSS kindred are likely to uncover more heterogeneity and potentially will increase our understanding of the structural requirements for proper assembly and function of the GPIb/IX receptor. 
